Kamada KMDA
NASDAQ KMDA
$7.78 -0.07 (-0.89%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kamada (KMDA) Operating Expenses (2012 - 2026)

Updated

Kamada (KMDA) reported Operating Expenses of $8.02 million for the quarter ended Jun 30, 2026, up 10.1% from $7.29 million a year earlier and up 8.2% from the prior quarter.

Analysis

Kamada (KMDA) Operating Expenses (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Kamada's Operating Expenses came in at $31.42 million, up 4.9% year-over-year; for the year ended Dec 31, 2025, it was $31.72 million, up 2.7% from the prior year.

  • Operating Expenses has increased for seven consecutive years, with a five-year compound annual growth rate of 6.0% (years ended Dec 2020 to Dec 2025).
  • By year, Operating Expenses came in at $30.89 million in the year ended Dec 31, 2024 (+9.1%), $28.31 million in the year ended Dec 31, 2023 (+9.0%), $25.98 million in the year ended Dec 31, 2022 (+8.3%) and $23.99 million in the year ended Dec 31, 2021 (+1.0%).
  • Five-year quarterly Operating Expenses spans a low of -$1.3 million in the quarter ended Sep 30, 2021 and a high of $8.58 million in the quarter ended Jun 30, 2024.
  • Year over year, Operating Expenses gained in five of the last eight quarters, with growth averaging 2.2%.
  • The high point for year-over-year Operating Expenses in five years was the quarter ended Mar 31, 2022 (growth of 36.6%); the low point was the quarter ended Jun 30, 2025 (a decline of 15.1%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $7.41 million (quarter ended Mar 31, 2026), $8.53 million (quarter ended Dec 31, 2025) and $7.46 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.56 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 6.68 Bn
10 Kamada 449.64 Mn 158.70 Mn 22.47 Mn 8.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.02 Mn
Mar 31, 2026 7.41 Mn
Dec 31, 2025 8.53 Mn
Sep 30, 2025 7.46 Mn
Jun 30, 2025 7.29 Mn
Mar 31, 2025 8.44 Mn
Dec 31, 2024 6.80 Mn
Sep 30, 2024 7.43 Mn
Jun 30, 2024 8.58 Mn
Mar 31, 2024 8.08 Mn
Dec 31, 2023 7.02 Mn
Sep 30, 2023 6.88 Mn
Jun 30, 2023 7.77 Mn
Mar 31, 2023 6.65 Mn
Dec 31, 2022 6.31 Mn
Sep 30, 2022 6.28 Mn
Jun 30, 2022 5.95 Mn
Mar 31, 2022 7.43 Mn
Dec 31, 2021 7.28 Mn
Sep 30, 2021 5.24 Mn
API Access

Kamada Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=KMDA&period=max&api_key=YOUR_API_KEY